Table 4.

Comparison of susceptibility profiles between ESBL and non-ESBL producing isolates

Antibiotic	ESBL (138)						Non-ESBL (235)						P- value
	S		I		R		S		I		R
	%	N	%	N	%	N	%	N	%	N	%	N
Amoxicillin	8.7	12	11.6	16	79.7	110	19.1	45	11.9	28	68.9	162	0.022
Amoxicillin-clavulanic acid	8	11	29.7	24	71.9	86	17.9	42	10.2	41	62.3	169	< 0.001
Cefuroxime	18.1	25	26.8	37	55.1	76	40.9	96	23.4	55	35.7	84	< 0.001
Cephalexin	31.2	43	10.1	14	58.7	81	43.8	103	12.3	29	43.8	103	0.02
Cefotaxime	22.5	31	0	0	77.5	107	60.4	142	5.1	12	34.5	81	< 0.001
Ceftriaxone	24.6	34	0	0	75.4	104	57.4	135	6.4	15	36.2	85	< 0.001
Ceftazidime	15.2	21	0	0	84.8	117	47.2	111	12.8	30	40	94	< 0.001
Imipenem	32.6	45	40.6	56	26.8	37	40.9	96	36.1	85	23	54	0.272
Amikacin	73.6	173	1.3	3	25.1	59	75.4	104	0.7	1	23.9	33	0.576
Gentamicin	38.4	53	23.2	32	37.7	52	48.5	114	19.1	45	32.3	76	0.165
Co-trimoxazole	17.4	24	23.2	32	59.4	82	79	33.6	27	11.5	54.9	129	< 0.001
Ciprofloxacin	39.9	55	34.8	48	25.4	35	46.8	110	23	54	30.2	71	0.046
Doxycycline	14.5	20	30.4	42	55.1	76	31.1	73	9.4	22	59.6	140	< 0.001